A Pilot Study of Mirabegron and Behavioral Modification Including Pelvic Floor Exercise for Overactive Bladder in Parkinson's Disease (MAESTRO)

NCT02092181 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

30

Enrollment

INDIV

Sponsor class

Conditions

Parkinsons Disease

Interventions

DRUG: Mirabegron
DRUG: Placebo

Sponsor

Daniel Burdick, MD

Collaborators

[object Object]